$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
武田降糖药曲格列汀2021年价格多少?进入国家医保报销目录了吗?
2025-10-19 11:44:20
Check Details
一周一次的降糖药曲格列汀给糖尿病患者带来了新选择
2025-10-19 11:44:20
Check Details
紧急情况下可对枫糖尿症患者静脉注射无BCAA补充剂
2025-10-19 11:44:20
Check Details
SGLT2抑制剂治疗三种慢性病的安全性分析
2025-10-19 11:44:20
Check Details
恩格列净可以长期吃吗?恩格列净吃多久可以停?
2025-10-19 11:44:20
Check Details
恩格列净服用后多久见效?恩格列净服用多久之后血糖能降下来?
2025-10-19 11:44:20
Check Details
欧唐静(恩格列净)进医保了没?恩格列净医保价格
2025-10-19 11:44:20
Check Details
恩格列净和达格列净区别在哪?恩格列净和达格列净哪个好?
2025-10-19 11:44:20
Check Details
非奈利酮减少2型糖尿病和慢性肾病患者新发的心房纤颤
2025-10-19 11:44:20
Check Details
曲格列汀是糖尿病最好的药吗?曲格列汀多少钱一盒?
2025-10-19 11:44:20
Check Details
曲格列汀有副作用吗?吃曲格列汀一个月要多少钱?
2025-10-19 11:44:20
Check Details
超长效降血糖特效药曲格列汀,糖尿病患者的福音
2025-10-19 11:44:20
Check Details
1
2
...
5464
5465
5466
5467
5468
5469
5470
...
10218
10219
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
2
Pegloticase (Krystexxa) Complete Medication Guide
3
Vemurafenib (Zelboraf) Complete Medication Guide
4
Guide to Long-Term Ramipril Use: Safety and Renal Function Management
5
Mechanism and Clinical Positioning of Leflunomide: A Comprehensive Guide to csDMARDs
6
Comprehensive Clinical Guide to Risankizumab (Skyrizi): Dosing, Contraindications, and Safety
7
Management Strategies and Long-Term Outcomes Following 6 Months of Pegloticase (Krystexxa) Therapy
8
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
9
Omaveloxolone (Skyclarys): Side Effect Management and Clinical Guide for Friedreich’s Ataxia
10
Linezolid for MRSA Pneumonia: Efficacy Evidence, Clinical Advantages, and Rational Use
11
Navigating Drug Interactions with Daprodustat: Risks, Adjustments, and Safety Protocols
12
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice